MicroRNA-146a acts as a guardian of the quality and longevity of hematopoietic stem cells in mice

eLife

Volumn 2013, Issue 2, 2013, Pages

  Zhao, Jimmy L ^a   Rao, Dinesh S ^b   O'Connell, Ryan M ^c   Garcia Flores, Yvette ^a   Baltimore, David ^a  

^a CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD150 ANTIGEN; CD45 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MICRORNA; MICRORNA 146A; MICRORNA 146B; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; MIRN146 MICRORNA, HUMAN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; BONE MARROW DEPRESSION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SELECTION; CHRONIC INFLAMMATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROID PRECURSOR CELL; FEMALE; FLOW CYTOMETRY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HISTOPATHOLOGY; LEUKOCYTE; LONGEVITY; LYMPHOCYTE; MOUSE; MYELOFIBROSIS; MYELOPROLIFERATIVE DISORDER; MYELOPROLIFERATIVE NEOPLASM; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SPLEEN WEIGHT; TARGET CELL; ANIMAL; CELL AGING; CYTOLOGY; GENETICS; HOMEOSTASIS; INFLAMMATION; METABOLISM; MUTANT MOUSE STRAIN;

ANIMALS; CELL AGING; HEMATOPOIETIC STEM CELLS; HOMEOSTASIS; INFLAMMATION; INTERLEUKIN-6; MICE; MICE, MUTANT STRAINS; MICRORNAS; NF-KAPPA B;

EID: 84879060116     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.00537     Document Type: Article

References (45)

1. Anderson LA, Pfeiffer RM, Landgren O, Gadalla S, Berndt SI, Engels EA. 2009. Risks of myeloid malignancies in patients with autoimmune conditions. Br J Cancer 100:822-8. doi: 10.1038/sj.bjc.6604935.
2. Baldridge MT, King KY, Boles NC, Weksberg DC, Goodell MA. 2010. Quiescent haematopoietic stem cells are activated by IFN-gamma in response to chronic infection. Nature 465:793-7. doi: 10.1038/nature09135.
3. Baltimore D. 2011. NF-kappaB is 25. Nat Immunol 12:683-5. doi: 10.1038/ni.2072.
4. Beerman I, Maloney WJ, Weissmann IL, Rossi DJ. 2010. Stem cells and the aging hematopoietic system. Curr Opin Immunol 22:500-6. doi: 10.1016/j.coi.2010.06.007.
5. Boldin MP, Baltimore D. 2012. MicroRNAs, new effectors and regulators of NF-kappaB. Immunol Rev 246:205-20. doi: 10.1111/j.1600-065X.2011.01089.x.
6. Boldin MP, Taganov KD, Rao DS, Yang L, Zhao JL, Kalwani M, et al. 2011. miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. J Exp Med 208:1189-201. doi: 10.1084/jem.20101823.
7. Brandt SJ, Bodine DM, Dunbar CE, Nienhuis AW. 1990. Dysregulated interleukin 6 expression produces a syndrome resembling Castleman's disease in mice. J Clin Invest 86:592-9. doi: 10.1172/JCI114749.
8. Esplin BL, Shimazu T, Welner RS, Garrett KP, Nie L, Zhang Q, et al. 2011. Chronic exposure to a TLR ligand injures hematopoietic stem cells. J Immunol 186:5367-75. doi: 10.4049/jimmunol.1003438.
9. Essers MA, Offner S, Blanco-Bose WE, Waibler Z, Kalinke U, Duchosal MA, et al. 2009. IFNalpha activates dormant haematopoietic stem cells in vivo. Nature 458:904-8. doi: 10.1038/nature07815.
10. Etzrodt M, Cortez-Retamozo V, Newton A, Zhao J, Ng A, Wildgruber M, et al. 2012. Regulation of monocyte functional heterogeneity by miR-146a and Relb. Cell Rep 1:317-24. doi: 10.1016/j.celrep.2012.02.009.
11. Gerondakis S, Banerjee A, Grigoriadis G, Vasanthakumar A, Gugasyan R, Sidwell T, et al. 2012. NF-kappaB subunit specificity in hemopoiesis. Immunol Rev 246:272-85. doi: 10.1111/j.1600-065X.2011.01090.x.
12. Gerondakis S, Grumont R, Gugasyan R, Wong L, Isomura I, Ho W, et al. 2006. Unravelling the complexities of the NF-kappaB signalling pathway using mouse knockout and transgenic models. Oncogene 25:6781-99. doi: 10.1038/sj.onc.1209944.
13. Grivennikov S, Karin E, Terzic J, Mucida D, Yu GY, Vallabhapurapu S, et al. 2009. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell 15:103-13. doi: 10.1016/j.ccr.2009.01.001.
14. Guo S, Lu J, Schlanger R, Zhang H, Wang JY, Fox MC, et al. 2010. MicroRNA miR-125a controls hematopoietic stem cell number. Proc Natl Acad Sci USA 107:14229-34. doi: 10.1073/pnas.0913574107.
15. Hasselbalch HC. 2012. Perspectives on chronic inflammation in essential thrombocythemia, polycythemia vera, and myelofibrosis: is chronic inflammation a trigger and driver of clonal evolution and development of accelerated atherosclerosis and second cancer? Blood 119:3219-25. doi: 10.1182/blood-2011-11-394775.
16. Hawley RG, Fong AZ, Burns BF, Hawley TS. 1992. Transplantable myeloproliferative disease induced in mice by an interleukin 6 retrovirus. J Exp Med 176:1149-63. doi: 10.1084/jem.176.4.1149.
17. Iliopoulos D, Hirsch HA, Struhl K. 2009. An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation. Cell 139:693-706. doi: 10.1016/j.cell.2009.10.014.
18. King KY, Goodell MA. 2011. Inflammatory modulation of HSCs: viewing the HSC as a foundation for the immune response. Nat Rev Immunol 11:685-92. doi: 10.1038/nri3062.
19. Kristinsson SY, Bjorkholm M, Hultcrantz M, Derolf AR, Landgren O, Goldin LR. 2011. Chronic immune stimulation might act as a trigger for the development of acute myeloid leukemia or myelodysplastic syndromes. J Clin Oncol 29:2897-903. doi: 10.1200/JCO.2011.34.8540.
20. Lee EG, Boone DL, Chai S, Libby SL, Chien M, Lodolce JP, et al. 2000. Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. Science 289:2350-4. doi: 10.1126/science.289.5488.2350.
21. Liew FY, Xu D, Brint EK, O'Neill LA. 2005. Negative regulation of toll-like receptor-mediated immune responses. Nat Rev Immunol 5:446-58. doi: 10.1038/nri1630.
22. Lippert E, Karrasch T, Sun X, Allard B, Herfarth HH, Threadgill D, et al. 2009. Gnotobiotic IL-10; NF-kappaB mice develop rapid and severe colitis following Campylobacter jejuni infection. PLoS One 4:e7413. doi: 10.1371/journal.pone.0007413.
23. Lu LF, Boldin MP, Chaudhry A, Lin LL, Taganov KD, Hanada T, et al. 2010. Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Cell 142:914-29. doi: 10.1016/j.cell.2010.08.012.
24. Magness ST, Jijon H, Van Houten Fisher N, Sharpless NE, Brenner DA, Jobin C. 2004. In vivo pattern of lipopolysaccharide and anti-CD3-induced NF-kappa B activation using a novel gene-targeted enhanced GFP reporter gene mouse. J Immunol 173:1561-70.
25. Mayle A, Luo M, Jeong M, Goodell MA. (2013). Flow cytometry analysis of murine hematopoietic stem cells. Cytometry A 83:27-37. doi: 10.1002/cyto.a.22093.
26. Nagai Y, Garrett KP, Ohta S, Bahrun U, Kouro T, Akira S, et al. 2006. Toll-like receptors on hematopoietic progenitor cells stimulate innate immune system replenishment. Immunity 24:801-12. doi: 10.1016/j.immuni.2006.04.008.
27. Nahid MA, Satoh M, Chan EK. 2011. MicroRNA in TLR signaling and endotoxin tolerance. Cell Mol Immunol 8:388-403. doi: 10.1038/cmi.2011.26.
28. Naugler WE, Karin M. 2008. The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer. Trends Mol Med 14:109-19. doi: 10.1016/j.molmed.2007.12.007.
29. Nimer SD. 2008a. MDS: a stem cell disorder-but what exactly is wrong with the primitive hematopoietic cells in this disease?. Hematology Am Soc Hematol Educ Program 43-51. doi: 10.1182/asheducation-2008.1.43.
30. Nimer SD. 2008b. Myelodysplastic syndromes. Blood 111:4841-51. doi: 10.1182/blood-2007-08-078139.
31. O'Connell RM, Chaudhuri AA, Rao DS, Baltimore D. 2009. Inositol phosphatase SHIP1 is a primary target of miR-155. Proc Natl Acad Sci USA 106:7113-8. doi: 10.1073/pnas.0902636106.
32. O'Connell RM, Chaudhuri AA, Rao DS, Gibson WS, Balazs AB, Baltimore D. 2010. MicroRNAs enriched in hematopoietic stem cells differentially regulate long-term hematopoietic output. Proc Natl Acad Sci USA 107:14235-40. doi: 10.1073/pnas.1009798107.
33. Rakoff-Nahoum S, Medzhitov R. 2009. Toll-like receptors and cancer. Nat Rev Cancer 9:57-63. doi: 10.1038/nrc2541.
34. Reynaud D, Pietras E, Barry-Holson K, Mir A, Binnewies M, Jeanne M, et al. 2011. IL-6 controls leukemic multipotent progenitor cell fate and contributes to chronic myelogenous leukemia development. Cancer Cell 20:661-73. doi: 10.1016/j.ccr.2011.10.012.
35. Rhyasen GW, Starczynowski DT. 2012. Deregulation of microRNAs in myelodysplastic syndrome. Leukemia 26:13-22. doi: 10.1038/leu.2011.221.
36. Ruland J. 2011. Return to homeostasis: downregulation of NF-kappaB responses. Nat Immunol 12:709-14. doi: 10.1038/ni.2055.
37. Salminen A, Huuskonen J, Ojala J, Kauppinen A, Kaarniranta K, Suuronen T. 2008. Activation of innate immunity system during aging: NF-kB signaling is the molecular culprit of inflamm-aging. Ageing Res Rev 7:83-105. doi: 10.1016/j.arr.2007.09.002.
38. Seita J, Weissman IL. 2010. Hematopoietic stem cell: self-renewal versus differentiation. Wiley Interdiscip Rev Syst Biol Med 2:640-53. doi: 10.1002/wsbm.86.
39. Sekeres MA, Schoonen WM, Kantarjian H, List A, Fryzek J, Paquette R, et al. 2008. Characteristics of US patients with myelodysplastic syndromes: results of six cross-sectional physician surveys. J Natl Cancer Inst 100:1542-51. doi: 10.1093/jnci/djn349.
40. Starczynowski DT, Kuchenbauer F, Argiropoulos B, Sung S, Morin R, Muranyi A, et al. 2010. Identification of miR-145 and miR-146a as mediators of the 5q-syndrome phenotype. Nat Med 16:49-58. doi: 10.1038/nm.2054.
41. Yang L, Boldin MP, Yu Y, Liu CS, Ea CK, Ramakrishnan P, et al. 2012. miR-146a controls the resolution of T cell responses in mice. J Exp Med 209:1655-70. doi: 10.1084/jem.20112218.
42. Zhang H, Nguyen-Jackson H, Panopoulos AD, Li HS, Murray PJ, Watowich SS. 2010. STAT3 controls myeloid progenitor growth during emergency granulopoiesis. Blood 116:2462-71. doi: 10.1182/blood-2009-12-259630.
43. Zhang P, Iwama A, Datta MW, Darlington GJ, Link DC, Tenen DG. 1998. Upregulation of interleukin 6 and granulocyte colony-stimulating factor receptors by transcription factor CCAAT enhancer binding protein alpha (C/EBP alpha) is critical for granulopoiesis. J Exp Med 188:1173-84. doi: 10.1073/pnas.88.23.10638.
44. Zhao C, Xiu Y, Ashton J, Xing L, Morita Y, Jordan CT, et al. 2012. Noncanonical NF-kappaB signaling regulates hematopoietic stem cell self-renewal and microenvironment interactions. Stem Cells 30:709-18. doi: 10.1002/stem.1050.
45. Zhao JL, Rao DS, Boldin MP, Taganov KD, O'Connell RM, Baltimore D. 2011. NF-kappaB dysregulation in microRNA-146a-deficient mice drives the development of myeloid malignancies. Proc Natl Acad Sci USA 108:9184-9. doi: 10.1073/pnas.1105398108.